Table 1.
Baseline characteristics of cases (n=100) and controls (n=86)
| Variable | Mean±SD | P | |
|---|---|---|---|
|
| |||
| Cases (n=100) | Control (n=86) | ||
| Age (years) | 64.27±5.81 | 63.05±5.24 | 0.24 |
| BMI (kg/m2) | 25.98±3.86 | 25.36±4.1 | 0.43 |
| WC (cm) | 86±5.2 | 82±5.8 | <0.01 |
| WHR | 0.81±0.04 | 0.78±0.08 | <0.01 |
| SBP (mm Hg) | 140.65±8.2 | 120.38±10.1 | <0.01 |
| DBP (mm Hg) | 96.5±9.88 | 82.1±4.2 | <0.01 |
| Total cholesterol (mg/dl) | 201.55±40.1 | 190.03±22.8 | 0.02 |
| LDL-C (mg/dl) | 125.62±36.8 | 120.65±28.11 | 0.20 |
| HDL-C (mg/dl) | 36.75±8.08 | 40.34±9.12 | <0.001 |
| TG (mg/dl) | 221.5±88.60 | 122.92±50.1 | <0.01 |
| E2 (pg/ml) | 11.18±2.39 | 11.23±2.42 | 0.7 |
| Total testotsterone (ng/dl) | 20.08±2.94 | 12.53±2.64 | <0.01 |
| E2/T ratio | 0.10±0.72 | 0.11±0.08 | 0.06 |
| SHBG (mcg/ml) | 3.08±0.48 | 3.85±0.39 | <0.01 |
| FPG (mg/dl) | 130.52±14.32 | 78.32±8.2 | <0.01 |
| PPPG (mg/dl) | 248.75±11.38 | 124±9.26 | <0.01 |
| HbA1c | 7.84±1.45 | 5.24±0.32 | <0.01 |
| Fasting insulin levels (microunits/ml) | 14±4.8 | 4.5±2.2 | <0.01 |
| HS-CRP (mg/L) | 5.92±4.08 | 2.70±0.9 | <0.01 |
| Free testosterone index (%) | 2.50±0.52 | 2.11±0.69 | <0.01 |
| HOMA-IR | 4.52±2.84 | 0.9±0.2 | <0.01 |
BMI: Body mass index, WC: Waist circumference, WHR: Waist hip ratio, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, LDL-C: Low-density lipoprotein cholesterol, HDL-C: High-density lipoprotein cholesterol, TG: Triglyceride, SHBG: Sex hormone binding globulins, FPG: Fasting plasma glucose, PPPG: Postprandial plasma glucose, HbA1c: Hemoglobin A1c, HS-CRP: High sensitivity C reactive protein, HOMA-IR: Homeostasis model assessment-insulin resistance, SD: Standard deviation, E2: Estradiol